Drug Procurement
Drug procurement is one of the most important aspects for success of a pharmacy business. It involves picking the best overall strategy based on your business today and three years from now.
With 4PillarxRx, you're working with well respected industry executives who have purchased Billions in pharmaceuticals for multiple pharmacy businesses. They have negotiated over 18 material prime vendor agreements with companies such as Cardinal Health, Amerisource Bergen and McKesson corporation. They have extensive experience in implementing direct sourcing agreements for small to large pharmacies buying their generic drugs direct from manufacturer at savings in excess of 38%.
Just recently, they have aided one of large client in rebidding its prime vendor agreement and managing its generic bid process. The annual savings from the initiative exceeded $98M annually as well as another large digital health company saving $21.5M over three years. We have extensive experience and success in both deal types. We have a proven track record, hands on experience and key strategic contacts in pharmaceutical industry. We are an active advisor to Federal Government on drug pricing and removal of safe harbor loophole that will dissolve pharmaceutical rebate agreements.
With 4PillarxRx, you're working with well respected industry executives who have purchased Billions in pharmaceuticals for multiple pharmacy businesses. They have negotiated over 18 material prime vendor agreements with companies such as Cardinal Health, Amerisource Bergen and McKesson corporation. They have extensive experience in implementing direct sourcing agreements for small to large pharmacies buying their generic drugs direct from manufacturer at savings in excess of 38%.
Just recently, they have aided one of large client in rebidding its prime vendor agreement and managing its generic bid process. The annual savings from the initiative exceeded $98M annually as well as another large digital health company saving $21.5M over three years. We have extensive experience and success in both deal types. We have a proven track record, hands on experience and key strategic contacts in pharmaceutical industry. We are an active advisor to Federal Government on drug pricing and removal of safe harbor loophole that will dissolve pharmaceutical rebate agreements.
